TGFBR3 inhibits progression of papillary thyroid cancer by inhibiting the PI3K/AKT pathway and EMT
Background: Transforming growth factor beta receptor III (TGFBR3) has been shown to play a tumor-suppressive role in a variety of cancers. However, its role in papillary thyroid cancer (PTC) remains unknown. Method: TGFBR3 expression levels in PTC were analyzed utilizing The Cancer Genome Atlas (T...
Saved in:
| Main Authors: | Hanrong Zhang, Junxin Chen, Xin Chen, Chuimian Zeng, Pengyuan Zhang, Jiewen Jin, Haipeng Xiao, Yanbing Li, Hongyu Guan, Hai Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bioscientifica
2024-11-01
|
| Series: | Endocrine Connections |
| Subjects: | |
| Online Access: | https://ec.bioscientifica.com/view/journals/ec/13/12/EC-24-0270.xml |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of USP11 attenuates sepsis-associated acute kidney injury by downregulating TGFBR2/Smad3 signaling
by: Lu Wang, et al.
Published: (2025-06-01) -
Decoding clinical diversity in monogenic TGFBR1 and TGFBR2 mutations: insights into the interplay of molecular mechanisms and hypomorphicity
by: Fadia Abu-Sailik, et al.
Published: (2025-06-01) -
CCDC110 promotes the progression of hepatocellular carcinoma by activating the TGF-β/SMAD signaling pathway through targeted regulation of TGFBR1
by: Hao Shen, et al.
Published: (2025-05-01) -
Ginkgolide B Inhibits EMT and Promotes Pyroptosis in Gastric Cancer via AKT/mTOR Pathway
by: Lu X, et al.
Published: (2025-04-01) -
ITGA3–MET interaction promotes papillary thyroid cancer progression via ERK and PI3K/AKT pathways
by: Youmian Lan, et al.
Published: (2025-12-01)